TelyRx Holdings Inc. is on the rise, with a notable gain of 1.28% in the last trading session.
In a market that can often be unpredictable, TelyRx Holdings Inc. (TELY.TO) has caught investor attention with a positive move of 1.28% in today's trading. This uptick comes as the company continues to navigate its growth, showing resilience in a challenging landscape.
Investor takeaway: Keep an eye on TelyRx's performance as it reports increasing revenues, which could signal a positive outlook for the company's future.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$73.09M
52W high
$4.25
52W low
$2.00
1W change
+10.20%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 122.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+122.2% Upside
Current Price
C$2.70
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
102.6%
Annualized
90-Day Vol
97.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.26
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.54 | C$1.79 โ C$3.62 |
| 60 trading days | C$2.40 | C$1.45 โ C$3.95 |
| 90 trading days | C$2.26 | C$1.22 โ C$4.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
TelyRx Holdings Inc. closes at CA$2.38
The stock has a market capitalization of approximately CA$62.5 million, highlighting its position as a smaller player in the market.
Bull case
TelyRx reported a revenue increase to $19.4 million in Q1 2026, up from $14.3 million in the previous quarter. This strong growth potential could attract more investors, driving the stock price upward.
Bear case
Despite the recent gains, TelyRx faces challenges, including a net loss of $4.7 million reported for Q1 2026. Investors should remain cautious, as the company has yet to achieve profitability, which could impact long-term stock performance.
Recent Performance Overview
TelyRx Holdings Inc. closed at CA$2.38, marking a 1.28% increase in the last trading session. This gain is a positive indicator amidst the company's ongoing efforts to increase its revenue and market presence.
Financial Highlights
The latest financial results revealed a revenue increase to $19.4 million in Q1 2026, up from $14.3 million in Q4 2025. Despite this growth, the company reported a net loss of $4.7 million, which investors should consider when evaluating the stock's potential.
Looking Ahead
As TelyRx continues to expand its revenue streams, investors are encouraged to monitor its financial developments closely. The recent performance may indicate a shift in investor sentiment, but the path to profitability remains a critical factor for long-term success. For more insights, check out the TELY.TO stock page.
Advertisement
